An international research team including scientists from the University of Cologne have identified a new mechanism for the development of Parkinson’s disease, which could prove to be the starting point for the development of a more targeted therapy. The results of the study “Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson’s disease’ have been published in Nature Communications.
Read More
Health Rss 